tiprankstipranks
Annexon Biosciences (ANNX)
NASDAQ:ANNX
US Market

Annexon Biosciences (ANNX) Financial Statements

644 Followers

Annexon Biosciences Financial Overview

Annexon Biosciences's market cap is currently ―. The company's EPS TTM is $-1.897; its P/E ratio is -3.63; Annexon Biosciences is scheduled to report earnings on May 6, 2024, and the estimated EPS forecast is $-0.36. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Sep 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue$ 400.00K$ 600.00K$ 600.00K$ 400.00K$ 800.00K
Gross Profit$ 400.00K$ 600.00K$ 600.00K$ 400.00K$ 800.00K
EBIT$ -30.01M$ -34.78M$ -37.69M$ -41.24M$ -36.70M
EBITDA$ -29.43M$ -34.55M$ 0.00-$ -36.09M
Net Income Common Stockholders$ -27.89M$ -32.48M$ -35.19M$ -38.68M$ -34.38M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 259.72M$ 165.27M$ 192.94M$ 228.16M$ 242.66M
Total Assets$ 297.67M$ 203.82M$ 233.01M$ 268.78M$ 285.10M
Total Debt$ 31.36M$ 31.51M$ 32.01M$ 32.51M$ 32.86M
Net Debt$ -228.36M$ -133.76M$ -160.92M$ -195.66M$ -209.80M
Total Liabilities$ 47.12M$ 46.98M$ 48.29M$ 53.92M$ 53.90M
Stockholders Equity$ 250.56M$ 156.84M$ 184.75M$ 214.86M$ 231.19M
Cash Flow-
Free Cash Flow$ -23.48M$ -28.31M--$ -27.42M
Operating Cash Flow$ -23.48M$ -28.29M--$ -27.14M
Investing Cash Flow$ -2.18M$ 47.84M--$ -43.62M
Financing Cash Flow$ 117.60M---$ 108.00K
Currency in USD

Annexon Biosciences Earnings and Revenue History

Annexon Biosciences Debt to Assets

Annexon Biosciences Cash Flow

Annexon Biosciences Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis